Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: caly who wrote (1022)	9/4/2000 10:37:21 AM
From: david james	Respond to of 1298

In "Bizarre News" Japanese Tobacco Company Buys Into Lung Cancer Vaccine Foster City, Calif. - More than ever before, the lives of cigarette smokers are in the hands of the tobacco companies, and one company in particular. The pharmaceutical unit of Japan Tobacco, the world's third-largest cigarette company, has invested heavily in a revolutionary lung cancer vaccine being produced by a U.S. firm. Cell Genesys, Inc. announced a payment of $4.5 million following the completion of a clinical trial of GVAX lung cancer vaccine. If successful you'll be able to buy both your death and life from the same brand. lorenz.mur.csu.edu.au